{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:35:05Z","timestamp":1791758105606,"version":"4.3.4"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["PJT-148684"],"award-info":[{"award-number":["PJT-148684"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["MOP-130398"],"award-info":[{"award-number":["MOP-130398"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR Foundation","award":["FDN143262"],"award-info":[{"award-number":["FDN143262"]}]},{"name":"Toronto General Hospital Research Institute"},{"name":"TGHRI"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>Does HIV protease inhibitor (PI)-based combination antiretroviral therapy (cART) initiated at periconception affect key events in early pregnancy, i.e. decidualization and spiral artery remodeling?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Two PIs, lopinavir and darunavir, currently offered as cART options in HIV-positive pregnancies were evaluated, and we found that lopinavir-based cART, but not darunavir-based cART, impaired uterine decidualization and spiral artery remodeling in both human ex vivo and mouse in vivo experimental models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>Early initiation of cART is recommended for pregnant women living with HIV. However, poor birth outcomes are frequently observed in HIV-positive pregnancies exposed to PI-based cART, especially when it is initiated prior to conception. The correlation between early initiation of PI-cART and adverse birth outcomes is poorly understood, due to lack of data on the specific effects of PI-cART on the early stages of pregnancy involving uterine decidualization and spiral artery remodeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>Lopinavir and darunavir were evaluated in clinically relevant combinations using an ex vivo human first-trimester placenta-decidua explant model, an in vitro human primary decidual cell culture system, and an in vivo mouse pregnancy model. The first-trimester (gestational age, 6\u20138 weeks) human placenta-decidua tissue was obtained from 11 to 15 healthy women undergoing elective termination of pregnancy. C57Bl\/6 female mice (four\/treatment group) were administered either lopinavir-cART, darunavir-cART or water by oral gavage once daily starting on the day of plug detection until sacrifice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>Human: Spiral artery remodeling was assessed by immunohistochemical analysis of first-trimester placenta-decidua explant co-culture system. Trophoblast migration was measured using a placental explant culture. A primary decidual cell culture was used to evaluate the viability of immune cell populations by flow cytometry. Soluble factors, including biomarkers of decidualization and angiogenesis, were quantified by ELISA and Luminex assay using decidua-conditioned media.<\/jats:p>\n                    <jats:p>Mouse: In the mouse pregnancy model, gestational day 6.5 or 9.5 implantation sites were used to assess decidualization, spiral artery remodeling and uterine natural killer (uNK) cell numbers by immunohistochemistry. Transcription factor STAT3 was assayed by immunohistochemistry in both human decidua and mouse implantation sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>Lopinavir-cART, but not darunavir-cART, impaired uterine decidualization and spiral artery remodeling in both experimental models. Lopinavir-cART treatment was also associated with selective depletion of uNK cells, reduced trophoblast migration and defective placentation. The lopinavir-associated decidualization defects were attributed to a decrease in expression of transcription factor STAT3, known to regulate decidualization. Our results suggest that periconceptional initiation of lopinavir-cART, but not darunavir-cART, causes defective maturation of the uterine endometrium, leading to impairments in spiral artery remodeling and placentation, thus contributing to the poor birth outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LARGE SCALE DATA<\/jats:title>\n                    <jats:p>N\/A<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>The human first-trimester placenta\/decidua samples could only be obtained from healthy females undergoing elective termination of pregnancy. As biopsy is the only way to obtain first-trimester decidua from pregnant women living with HIV on PI-cART, ethics approval and participant consent are difficult to obtain. Furthermore, our animal model is limited to the study of cART and does not include HIV. HIV infection is also associated with immune dysregulation, inflammation, alterations in angiogenic factors and complement activation, all of which could influence decidual and placental vascular remodeling and modify any cART effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>Our findings provide mechanistic insight with direct clinical implications, rationalizing why the highest adverse birth outcomes are reported in HIV-positive pregnancies exposed to lopinavir-cART from conception. We demonstrate that dysregulation of decidualization is the mechanism through which lopinavir-cART, but not darunavir-cART, use in early pregnancy leads to poor birth outcomes. Although lopinavir is no longer a first-line regimen in pregnancy, it remains an alternate regimen and is often the only PI available in low resource settings. Our results highlight the need for reconsidering current guidelines recommending lopinavir use in pregnancy and indicate that lopinavir should be avoided especially in the first trimester, whereas darunavir is safe to use and should be the preferred PI in pregnancy.<\/jats:p>\n                    <jats:p>Further, in current times of the COVID-19 pandemic, lopinavir is among the top drug candidates which are being repurposed for inclusion in clinical trials world-over, to assess their therapeutic potential against the dangerous respiratory disease. Current trials are also testing the efficacy of lopinavir given prophylactically to protect health care workers and people with potential exposures. Given the current extraordinary numbers, these might include women with early pregnancies, who may or may not be cognizant of their gestational status. This is a matter of concern as it could mean that women with early pregnancies might be exposed to this drug, which can cause decidualization defects. Our findings provide evidence of safety concerns surrounding lopinavir use in pregnancy, that women of reproductive age considering participation in such trials should be made aware of, so they can make a fully informed decision.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>This work was supported by funding from the Canadian Institutes of Health Research (CIHR) (PJT-148684 and MOP-130398 to L.S.). C.D. received support from CIHR Foundation (FDN143262 to Stephen Lye). S.K. received a TGHRI postdoctoral fellowship. The authors declare that there are no conflicts of interest. L.S. reports personal fees from ViiV Healthcare for participation in a Women and Transgender Think Tank.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deaa151","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:29:47Z","timestamp":1591226987000},"page":"1781-1796","source":"Crossref","is-referenced-by-count":25,"title":["Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies"],"prefix":"10.1093","volume":"35","author":[{"given":"Smriti","family":"Kala","sequence":"first","affiliation":[{"name":"Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Dunk","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Acosta","sequence":"additional","affiliation":[{"name":"Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Serghides","sequence":"additional","affiliation":[{"name":"Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada"},{"name":"Department of Immunology and Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,26]]},"reference":[{"key":"2020080315204503400_deaa151-B1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/cid\/cix761","article-title":"Elevated levels of estradiol in human immunodeficiency virus-infected pregnant women on protease inhibitor-based regimens","volume":"66","author":"Balogun","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020080315204503400_deaa151-B2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/aji.12473","article-title":"Progesterone-regulated endometrial factors controlling implantation","volume":"75","author":"Bhurke","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"2020080315204503400_deaa151-B3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","article-title":"Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"2020080315204503400_deaa151-B4","doi-asserted-by":"crossref","first-page":"H664","DOI":"10.1152\/ajpheart.00733.2018","article-title":"Placental vascular abnormalities in the mouse alter umbilical artery wave reflections","volume":"316","author":"Cahill","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020080315204503400_deaa151-B5","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2007-08-105965","article-title":"Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy","volume":"111","author":"Carlino","year":"2008","journal-title":"Blood"},{"key":"2020080315204503400_deaa151-B6","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana","volume":"206","author":"Chen","year":"2012","journal-title":"J Infect Dis"},{"key":"2020080315204503400_deaa151-B7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-0378(02)00005-0","article-title":"Decidual natural killer cells: key regulators of placental development (a review)","volume":"57","author":"Croy","year":"2002","journal-title":"J Reprod Immunol"},{"key":"2020080315204503400_deaa151-B8","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1097\/01.LAB.0000101730.69754.5A","article-title":"A novel in vitro model of trophoblast-mediated decidual blood vessel remodeling","volume":"83","author":"Dunk","year":"2003","journal-title":"Lab Invest"},{"key":"2020080315204503400_deaa151-B9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/08820130802191466","article-title":"Promotion of angiogenesis by human endometrial lymphocytes","volume":"37","author":"Dunk","year":"2008","journal-title":"Immunol Invest"},{"key":"2020080315204503400_deaa151-B10","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1511691","article-title":"Benefits and risks of antiretroviral therapy for perinatal HIV prevention","volume":"375","author":"Fowler","year":"2016","journal-title":"N Engl J Med"},{"key":"2020080315204503400_deaa151-B11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/er.2014-1045","article-title":"Cyclic decidualization of the human endometrium in reproductive health and failure","volume":"35","author":"Gellersen","year":"2014","journal-title":"Endocr Rev"},{"key":"2020080315204503400_deaa151-B12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng0395-235","article-title":"Genomic imprinting of Mash2, a mouse gene required for trophoblast development","volume":"9","author":"Guillemot","year":"1995","journal-title":"Nat Genet"},{"key":"2020080315204503400_deaa151-B13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2353\/ajpath.2010.091105","article-title":"Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro","volume":"177","author":"Hazan","year":"2010","journal-title":"Am J Pathol"},{"key":"2020080315204503400_deaa151-B14","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1038\/srep13735","article-title":"FoxM1 directs STAT3 expression essential for human endometrial stromal decidualization","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"2020080315204503400_deaa151-B15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2018.09.008","article-title":"Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens","volume":"159","author":"Kala","year":"2018","journal-title":"Antiviral Res"},{"key":"2020080315204503400_deaa151-B16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/tmi.12858","article-title":"Placental pathology in HIV infection at term: a comparison with HIV-uninfected women","volume":"22","author":"Kalk","year":"2017","journal-title":"Trop Med Int Health"},{"key":"2020080315204503400_deaa151-B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","article-title":"Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia","volume":"69","author":"Kaufmann","year":"2003","journal-title":"Biol Reprod"},{"key":"2020080315204503400_deaa151-B18","doi-asserted-by":"crossref","first-page":"E1018","DOI":"10.1073\/pnas.1618433114","article-title":"Forkhead box a2 (FOXA2) is essential for uterine function and fertility","volume":"114","author":"Kelleher","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020080315204503400_deaa151-B19","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0611098104","article-title":"TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells","volume":"104","author":"Keskin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020080315204503400_deaa151-B20","first-page":"e53534","article-title":"Assessment of maternal vascular remodeling during pregnancy in the mouse uterus","author":"Kieckbusch","year":"2015","journal-title":"J Vis Exp"},{"key":"2020080315204503400_deaa151-B21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS"},{"key":"2020080315204503400_deaa151-B22","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/infdis\/jiv389","article-title":"Antiretroviral therapy in relation to birth outcomes among HIV-infected women: a cohort study","volume":"213","author":"Li","year":"2016","journal-title":"J Infect Dis"},{"key":"2020080315204503400_deaa151-B23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/cmi.2014.63","article-title":"Leukocyte driven-decidual angiogenesis in early pregnancy","volume":"11","author":"Lima","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"2020080315204503400_deaa151-B24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"2020080315204503400_deaa151-B25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/infdis\/jiv390","article-title":"Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room?","volume":"213","author":"Mofenson","year":"2016","journal-title":"J Infect Dis"},{"key":"2020080315204503400_deaa151-B26","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.1038\/s41598-018-24680-w","article-title":"HIV antiretroviral exposure in pregnancy induces detrimental placenta vascular changes that are rescued by progesterone supplementation","volume":"8","author":"Mohammadi","year":"2018","journal-title":"Sci Rep"},{"key":"2020080315204503400_deaa151-B27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1701-2163(15)30515-6","article-title":"Guidelines for the care of pregnant women living with HIV and interventions to reduce perinatal transmission: executive summary","volume":"36","author":"Money","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"2020080315204503400_deaa151-B28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/QAI.0000000000001871","article-title":"Placental structure in preterm birth among HIV-positive versus HIV-negative women in Kenya","volume":"80","author":"Obimbo","year":"2019","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020080315204503400_deaa151-B29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jiu393","article-title":"HIV protease inhibitor use during pregnancy is associated with decreased progesterone levels, suggesting a potential mechanism contributing to fetal growth restriction","volume":"211","author":"Papp","year":"2015","journal-title":"J Infect Dis"},{"key":"2020080315204503400_deaa151-B30","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1096\/fj.12-210310","article-title":"Uterine natural killer cells initiate spiral artery remodeling in human pregnancy","volume":"26","author":"Robson","year":"2012","journal-title":"FASEB J"},{"key":"2020080315204503400_deaa151-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000001770","article-title":"Use of antiretroviral therapy during pregnancy and adverse birth outcomes among women living with HIV-1 in low- and middle-income countries: a systematic review","volume":"79","author":"Saleska","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020080315204503400_deaa151-B32","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/cid\/cis198","article-title":"Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?","volume":"54","author":"Sibiude","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020080315204503400_deaa151-B33","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2353\/ajpath.2009.080995","article-title":"Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy","volume":"174","author":"Smith","year":"2009","journal-title":"Am J Pathol"},{"key":"2020080315204503400_deaa151-B34","doi-asserted-by":"crossref","first-page":"e0191389","DOI":"10.1371\/journal.pone.0191389","article-title":"Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age","volume":"13","author":"Snijdewind","year":"2018","journal-title":"PLoS One"},{"key":"2020080315204503400_deaa151-B35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/dbio.1997.8685","article-title":"Mash2 acts cell autonomously in mouse spongiotrophoblast development","volume":"190","author":"Tanaka","year":"1997","journal-title":"Dev Biol"},{"key":"2020080315204503400_deaa151-B36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fimmu.2016.00199","article-title":"The PHACS SMARTT Study: assessment of the safety of in utero exposure to antiretroviral drugs","volume":"7","author":"Van Dyke","year":"2016","journal-title":"Front Immunol"},{"key":"2020080315204503400_deaa151-B37","doi-asserted-by":"crossref","first-page":"8689436","DOI":"10.1155\/2016\/8689436","article-title":"Human decidual stromal cells as a component of the implantation niche and a modulator of maternal immunity","volume":"2016","author":"Vinketova","year":"2016","journal-title":"J Pregnancy"},{"key":"2020080315204503400_deaa151-B38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ijgo.12532","article-title":"Risk factors associated with preterm delivery and low delivery weight among HIV-exposed neonates in China","volume":"142","author":"Wang","year":"2018","journal-title":"Int J Gynaecol Obstet"},{"key":"2020080315204503400_deaa151-B39","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.placenta.2010.03.002","article-title":"Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field","volume":"31","author":"Whitley","year":"2010","journal-title":"Placenta"},{"key":"2020080315204503400_deaa151-B40","year":"2015"},{"key":"2020080315204503400_deaa151-B41","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1095\/biolreprod.109.083246","article-title":"HER1 signaling mediates extravillous trophoblast differentiation in humans","volume":"83","author":"Wright","year":"2010","journal-title":"Biol Reprod"},{"key":"2020080315204503400_deaa151-B42","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.placenta.2006.01.013","article-title":"EGF modulates trophoblast migration through regulation of Connexin 40","volume":"27(Suppl A","author":"Wright","year":"2006","journal-title":"Placenta"},{"key":"2020080315204503400_deaa151-B43","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2020080315204503400_deaa151-B44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10735-015-9613-8","article-title":"Decreased expression and activation of Stat3 in severe preeclampsia","volume":"46","author":"Zhang","year":"2015","journal-title":"J Mol Histol"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/8\/1781\/33560431\/deaa151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/8\/1781\/33560431\/deaa151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T15:22:32Z","timestamp":1596468152000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/8\/1781\/5876549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,26]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,7,26]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa151","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,7,26]]}}}